Wednesday May 23 | Rehab Management
Hanger CEO Thomas F. Kirk Announces Decision To Step Down
After 10 years of service, Hanger Orthopedic Group CEO Thomas F. Kirk recently announced his plans to retire.
Hanger's Thomas F. Kirk Announces Retirement as CEO; Board Appoints Vinit K. Asar as Successor
Hanger Orthopedic Group, Inc. today announced that Chief Executive Officer Thomas F. Kirk, 66, informed the board of directors of his decision to retire as CEO after over 10 years of service with the company.
Hanger Orthopedic Given "Neutral" Rating at Zacks
's stock had its "neutral" rating reiterated by Zacks in a research note issued to investors on Tuesday.
Hanger Orthopedic Given New $28.00 Price Target at Barclays Capital
The firm currently has an "overweight" rating on the stock. Shares of Hanger Orthopedic traded up 2.62% during mid-day trading on Thursday, hitting $23.90. Hanger Orthopedic has a one year low of $14.57 and a one year high of $27.90. The company has a market cap of $812.0 million and a P/E ratio of 14.47. The company last announced its quarterly ... (more)
Hanger Orthopedic Group Announces Clinical Trial Enrollment Completion
The Austin, Texas-based Hanger Orthopedic Group recently completed the enrollment of its INSTRIDE investigational device exemption clinical trial, which aims to determine the effectiveness of its WalkAide System in the rehabilitation of stroke survivors, according to a news release.